Li, J., Li, X., Ren, S., Chen, X., Zhang, Y., Zhou, F., . . . Hirsch, F. R. (2014). MiR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type. Impact Journals LLC.
Chicago-tyylinen lähdeviittausLi, Jiayu, et al. MiR-200c Overexpression Is Associated With Better Efficacy of EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Wild-type. Impact Journals LLC, 2014.
MLA-viiteLi, Jiayu, et al. MiR-200c Overexpression Is Associated With Better Efficacy of EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Wild-type. Impact Journals LLC, 2014.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.